Category: Kevin Outterson

Elections Have Consequences: Fungal Meningitis and Compounding Pharmacies

November 15th, 2012 in 2012, Kevin Outterson, Newsmakers, School of Law, Scientific American 0 comments

outterson_white-new_65wScientific American
Kevin Outterson, School of Law

32 deaths. 461 cases…and counting…

View article

Friends in Congress Have Helped Drug Compounders Avoid Tighter Rules

November 14th, 2012 in 2012, Kevin Outterson, New York Times, Newsmakers, School of Law 0 comments

outterson_white-new_65wNew York Times
Kevin Outterson, School of Law

Despite two decades of dire health warnings and threats of federal intervention, the specialty drugmakers at the center of the nation’s deadly meningitis outbreak have repeatedly staved off tougher federal oversight with the help of powerful allies in Congress…

View article

Regulating Compounding Pharmacies after NECC

November 13th, 2012 in 2012, Kevin Outterson, New England Journal of Medicine, Newsmakers, OP-EDs by BU Professors, School of Law 0 comments

outterson_white-new_65wNew England Journal of Medicine
By Kevin Outterson, School of Law

Food and Drug Administration (FDA) rules are often forged in crisis…

View article

Stronger FDA oversight may have averted meningitis outbreak: NEJM

November 8th, 2012 in 2012, Kevin Outterson, Los Angeles Times, Newsmakers, School of Law 0 comments

outterson_white-new_65wLos Angeles Times
Kevin Outterson, School of Law

So far, 31 people have died of fungal meningitis and nearly 400 more have been sickened by contaminated steroid shots made by the New England Compounding Center in Framingham, Mass…

View article

Analysis: U.S. foreign bribery penalties for drugmakers may lack bite

October 29th, 2012 in 2012, Kevin Outterson, Newsmakers, Reuters, School of Law 0 comments

outterson_white-new_65wReuters
Kevin Outterson, School of Law

Global drugmakers are paying tens of millions of dollars to settle U.S. allegations that they bribed their way across emerging markets, but harsher penalties may be needed to deter the practice in untapped regions where billions are at stake…

View article

After Meningitis Deaths, A Look At Drug Safety

October 25th, 2012 in 2012, Kevin Outterson, Newsmakers, NPR, School of Law 0 comments

outterson_white-new_65wNPR “Talk of the Nation”
Kevin Outterson, School of Law

Listen to audio

Bracing for More Regulation

October 25th, 2012 in 2012, Kevin Outterson, Newsmakers, School of Law 0 comments

outterson_white-new_65wGenetic Engineering & Biotechnology News
Kevin Outterson, School of Law

Compounding pharmacies are bracing for new regulation following the lethal fungal meningitis outbreak that authorities have attributed to contaminated steroid injections distributed by a Massachusetts manufacturer of custom medications…

View article

Meningitis Outbreak Puts Doctors, Regulators In New Territory

October 11th, 2012 in 2012, Kevin Outterson, Newsmakers, NPR, School of Law 0 comments

outterson_white-new_65wNPR “All Things Considered”
Kevin Outterson, School of Law

There’s new information on the ongoing outbreak of a rare meningitis caused by a fungus that somehow got into a steroid drug…

View article and listen to audio

Calls for more US oversight after tainted drug outbreak

October 11th, 2012 in 2012, AFP, Kevin Outterson, Newsmakers, School of Law 0 comments

outterson_white-new_65wAFP
Kevin Outterson, School of Law

A deadly meningitis outbreak in the United States blamed on a tainted drug has triggered outrage and calls for tighter regulation of the loosely controlled pharmaceutical compounding industry…

View article

The Meningitis Outbreak: What Can Compounding Pharmacies Do Next?

October 11th, 2012 in 2012, Forbes, Kevin Outterson, Newsmakers, School of Law 0 comments

outterson_white-new_65wForbes
Kevin Outterson, School of Law

Those of us who’ve habitually watched It’s A Wonderful Life over the decades well remember how protagonist Harry Bailey intervenes to prevent Mr. Gower, the local pharmacist, from accidentally poisoning a child…

View article